These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28517413)

  • 1. SU-D-BRB-04: FDG-PET Histogram Distances: Novel Predictors of Tumor Response to Chemoradiotherapy.
    Tan S; Zhang H; Kligerman S; Chen W; Kim G; Feigenberg S; D'Souza W; Suntharalingam M; Lu W
    Med Phys; 2012 Jun; 39(6Part3):3615. PubMed ID: 28517413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting pathologic tumor response to chemoradiotherapy with histogram distances characterizing longitudinal changes in 18F-FDG uptake patterns.
    Tan S; Zhang H; Zhang Y; Chen W; D'Souza WD; Lu W
    Med Phys; 2013 Oct; 40(10):101707. PubMed ID: 24089897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Anal Cancer Recurrence After Chemoradiotherapy Using Quantitative Image Features Extracted From Serial
    Wang J; Zhang H; Chuong M; Latifi K; Tan S; Choi W; Hoffe S; Shridhar R; Lu W
    Front Oncol; 2019; 9():934. PubMed ID: 31612104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.
    van Stiphout RG; Lammering G; Buijsen J; Janssen MH; Gambacorta MA; Slagmolen P; Lambrecht M; Rubello D; Gava M; Giordano A; Postma EO; Haustermans K; Capirci C; Valentini V; Lambin P
    Radiother Oncol; 2011 Jan; 98(1):126-33. PubMed ID: 21176986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer.
    Jayachandran P; Pai RK; Quon A; Graves E; Krakow TE; La T; Loo BW; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):471-7. PubMed ID: 22381904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
    Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
    Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bin Ratio-Based Histogram Distances and Their Application to Image Classification.
    Hu W; Xie N; Hu R; Ling H; Chen Q; Yan S; Maybank S
    IEEE Trans Pattern Anal Mach Intell; 2014 Dec; 36(12):2338-52. PubMed ID: 26353143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal masses in patients with cancer: PET/CT characterization with combined CT histogram and standardized uptake value PET analysis.
    Perri M; Erba P; Volterrani D; Guidoccio F; Lazzeri E; Caramella D; Mariani G
    AJR Am J Roentgenol; 2011 Jul; 197(1):209-16. PubMed ID: 21701032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Chennupati SK; Quon A; Kamaya A; Pai RK; La T; Krakow TE; Graves E; Koong AC; Chang DT
    Am J Clin Oncol; 2012 Aug; 35(4):334-9. PubMed ID: 21422989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction.
    Yip SS; Coroller TP; Sanford NN; Huynh E; Mamon H; Aerts HJ; Berbeco RI
    Phys Med Biol; 2016 Jan; 61(2):906-22. PubMed ID: 26738433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [(18)F]FDG-PET/CT metabolic parameters as useful prognostic factors in cervical cancer patients treated with chemo-radiotherapy.
    Herrera FG; Breuneval T; Prior JO; Bourhis J; Ozsahin M
    Radiat Oncol; 2016 Mar; 11():43. PubMed ID: 26984385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET predicts pathological response to preoperative chemoradiotherapy in patients with primary rectal cancer: a meta-analysis.
    Li C; Lan X; Yuan H; Feng H; Xia X; Zhang Y
    Ann Nucl Med; 2014 Jun; 28(5):436-46. PubMed ID: 24623152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.
    Erasmus JJ; Munden RF; Truong MT; Ho JJ; Hofstetter WL; Macapinlac HA; Correa AM; Wu TT; Bruzzi JF; Marom EM; Sabloff BS; Ajani JA; Komaki R; Liao Z; Lee JH; Fukami N; Bresalier R; Swisher SG
    J Thorac Oncol; 2006 Jun; 1(5):478-86. PubMed ID: 17409902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.
    Nakajo M; Nakajo M; Jinguji M; Fukukura Y; Nakabeppu Y; Tani A; Yoshiura T
    Br J Radiol; 2015; 88(1055):20150552. PubMed ID: 26337605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of response to definitive chemoradiotherapy in esophageal cancer using positron emission tomography.
    Kato H; Fukuchi M; Miyazaki T; Nakajima M; Tanaka N; Inose T; Kimura H; Faried A; Saito K; Sohda M; Fukai Y; Masuda N; Manda R; Ojima H; Tsukada K; Oriuchi N; Endo K; Nonaka T; Shioya M; Ishikawa H; Sakurai H; Nakano T; Kuwano H
    Anticancer Res; 2007; 27(4C):2627-33. PubMed ID: 17695425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma.
    Swisher SG; Erasmus J; Maish M; Correa AM; Macapinlac H; Ajani JA; Cox JD; Komaki RR; Hong D; Lee HK; Putnam JB; Rice DC; Smythe WR; Thai L; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Cancer; 2004 Oct; 101(8):1776-85. PubMed ID: 15386332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the Temporal Changes in Positron-Emission-Tomography-Imaging-Based Textural Features and Pathologic Response and Survival in Esophageal Cancer Patients.
    Yip SS; Coroller TP; Sanford NN; Mamon H; Aerts HJ; Berbeco RI
    Front Oncol; 2016; 6():72. PubMed ID: 27066454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying local tumor morphological changes with Jacobian map for prediction of pathologic tumor response to chemo-radiotherapy in locally advanced esophageal cancer.
    Riyahi S; Choi W; Liu CJ; Zhong H; Wu AJ; Mechalakos JG; Lu W
    Phys Med Biol; 2018 Jul; 63(14):145020. PubMed ID: 29911659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.